成大生物涨5.03%创近4个月新高产品结构优化与估值修复预期驱动

智选洞察2025-07-14

成大生物股价今日表现强势，截至10点46分，公司股价上涨5.03%，报27.98元/股，创近4个月以来新高。资金博弈与估值分歧共振成大生物股价波动受短期资金博弈与板块轮动影响明显。截至7月11日，主力资金单日净流入93.2万元，前一交易日则净流出超500万元，资金面剧烈波动反映市场分歧。医药生物板块年内涨幅仅0.43%（截至7月10日），弱于周期股表现，防御属性资产阶段性承压。公司狂犬疫苗收入占...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551978071?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-14 10:46","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551978071","market":"sh","top_or_hot":-1,"title":"成大生物涨5.03%创近4个月新高 产品结构优化与估值修复预期驱动","media":"智选洞察","content":"<div>\n<p>成大生物股价今日表现强势，截至10点46分，公司股价上涨5.03%，报27.98元/股，创近4个月以来新高。资金博弈与估值分歧共振成大生物股价波动受短期资金博弈与板块轮动影响明显。截至7月11日，主力资金单日净流入93.2万元，前一交易日则净流出超500万元，资金面剧烈波动反映市场分歧。医药生物板块年内涨幅仅0.43%（截至7月10日），弱于周期股表现，防御属性资产阶段性承压。公司狂犬疫苗收入占...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104648a6a7a43c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>成大生物涨5.03%创近4个月新高 产品结构优化与估值修复预期驱动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n成大生物涨5.03%创近4个月新高 产品结构优化与估值修复预期驱动\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-14 10:46 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104648a6a7a43c&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>成大生物股价今日表现强势，截至10点46分，公司股价上涨5.03%，报27.98元/股，创近4个月以来新高。资金博弈与估值分歧共振成大生物股价波动受短期资金博弈与板块轮动影响明显。截至7月11日，主力资金单日净流入93.2万元，前一交易日则净流出超500万元，资金面剧烈波动反映市场分歧。医药生物板块年内涨幅仅0.43%（截至7月10日），弱于周期股表现，防御属性资产阶段性承压。公司狂犬疫苗收入占...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104648a6a7a43c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688739","symbol_name":"成大生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104648a6a7a43c&s=b","article_id":"2551978071","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104648a6a7a43c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551978071","pubTimestamp":1752461200,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"成大生物股价今日表现强势，截至10点46分，公司股价上涨5.03%，报27.98元/股，创近4个月以来新高。医药生物板块年内涨幅仅0.43%，弱于周期股表现，防御属性资产阶段性承压。公司狂犬疫苗收入占比超91%，产品集中度高叠加政策预期扰动，部分资金选择获利了结。技术壁垒与管线突破构筑价值锚点长期看，成大生物在狂犬疫苗领域的领先地位及全球化战略仍是核心支撑。机构普遍认为，公司现金流稳健，但短期估值修复需更多催化剂支撑。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688739":"成大生物","BK0239":"医药制造"},"translate_title":"Chengda Biotech rose 5.03%, hitting a new high in the past 4 months, driven by product structure optimization and valuation restoration expectations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688739":1},"content_text":"成大生物股价今日表现强势，截至10点46分，公司股价上涨5.03%，报27.98元/股，创近4个月以来新高。资金博弈与估值分歧共振成大生物股价波动受短期资金博弈与板块轮动影响明显。截至7月11日，主力资金单日净流入93.2万元，前一交易日则净流出超500万元，资金面剧烈波动反映市场分歧。医药生物板块年内涨幅仅0.43%（截至7月10日），弱于周期股表现，防御属性资产阶段性承压。公司狂犬疫苗收入占比超91%，产品集中度高叠加政策预期扰动，部分资金选择获利了结。当前动态市盈率34.93倍（截至7月14日），较行业中枢溢价约15%，估值性价比争议加剧筹码交换。技术壁垒与管线突破构筑价值锚点长期看，成大生物在狂犬疫苗领域的领先地位及全球化战略仍是核心支撑。境外收入占比提升至11.7%，带状疱疹疫苗等管线若获临床突破，或打开第二增长曲线。市净率1.25倍处于近三年低位，2.83%的股息率在医药板块凸显防御价值。国金证券指出，若下半年海外认证落地，估值或向35倍市盈率修复。技术面上，股价站稳20日均线（截至7月14日），但需警惕行业政策变化及研发进展不及预期风险。机构普遍认为，公司现金流稳健，但短期估值修复需更多催化剂支撑。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551978071","isCrawlerRequest":true}

成大生物涨5.03%创近4个月新高 产品结构优化与估值修复预期驱动

精彩评论

成大生物涨5.03%创近4个月新高产品结构优化与估值修复预期驱动